Globally, chronic pain affects approximately 55 out of 1,000 people annually, with India seeing 20% of its adult population (180–200 million people) suffering from this condition. Current standard treatments like pharmacotherapy and invasive procedures have significant long-term side effects and are highly costly, leading to a shift towards the growing popularity of non-invasive and non-pharmacological therapies.
Key Growth Drivers include the following:

1. Rising Chronic Pain Cases - Conditions like arthritis, fibromyalgia, back pain, and migraines are increasing.
2. Preference for Non-Pharmacological Treatments - Non-invasive options avoid risks of drug side effects.
3. Technological Advancements - AI-enabled, portable, wearable devices enhance treatment accuracy and convenience.
4. At-Home Healthcare Demand - Post-pandemic trends emphasize remote and self-managed solutions.
5. Higher Healthcare Investment - Governments and private sectors aim to mitigate chronic pain’s economic impact.

This shift supports better accessibility, affordability, and patient compliance for managing chronic pain.
 Advancements in pain management are revolutionizing chronic pain treatment with non-invasive, patient-friendly options. Virtual Reality (VR) therapy offers immersive visual experiences, while wearable devices like smart patches and electrotherapy units provide portable relief through vibrations, electrical stimulation, or heat. Neuromodulation devices target neurological pain with electromagnetic pulses. Regenerative treatments such as Platelet-Rich Plasma (PRP) and stem cell therapies promote tissue repair and reduce inflammation. High-Intensity Focused Ultrasound (HIFU) uses heat to disrupt pain signals, aiding musculoskeletal pain. Cryotherapy chambers, with their extreme cold, deliver anti-inflammatory and muscle-relaxing benefits, offering effective chronic pain relief.The global market for pain management solutions is projected to reach US$ 13.11B by 2030, growing at a CAGR of 9.4% from US$ 7.65B in 2024. The Indian market is also witnessing rapid growth, expected to increase from US$ 180M in 2024 to US$ 330M by 2030, representing a CAGR of 11.3%. These growth trends highlight the rising demand for innovative and non-invasive pain management therapies globally and within India.Investor funding is accelerating the development of portable pain management devices utilizing laser therapy, TENS, and neurostimulators. In October 2024, Ortholazer raised US$ 7M in Series A funding to advance its MLS M8 Robotic Laser Therapy for orthopedic pain and inflammation. In March 2024, Nalu Medical secured US$ 85M in Series E funding for its Nalu Neurostimulation System, a clinical-stage peripheral nerve stimulation device for neurological pain relief.